ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,491Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 387

$712K Total Retail Price of All Prescriptions

Rank: 70 out of 387

334 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

29% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,966 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
FUROSEMIDE 608 540 1 7
HYDROCODONE-ACETAMINOPHEN 427 366 S3 2 1
LEVOTHYROXINE SODIUM 417 388 3 2
OMEPRAZOLE 402 329 4 4
SIMVASTATIN 378 323 5 5
LISINOPRIL 357 331 6 3
NAMENDA 355 340 7 35
POTASSIUM CHLORIDE 327 275 8 9
NYSTATIN 315 310 9 147
DONEPEZIL HCL 283 283 10 27
GABAPENTIN 270 244 11 10
METOPROLOL TARTRATE 254 223 12 11
SERTRALINE HCL 193 167 13 23
WARFARIN SODIUM 191 155 14 17
CITALOPRAM HBR 188 174 15 19
POLYETHYLENE GLYCOL 3350 185 176 16 57
MIRTAZAPINE 165 160 17 64
GLIPIZIDE 142 133 18 63
RISPERIDONE 140 118 19 70
DILTIAZEM HCL 135 132 20 187
CLONIDINE HCL 132 126 21 38
ATORVASTATIN CALCIUM 120 104 22 13
ALENDRONATE SODIUM 117 117 23 31
DIGOXIN 114 113 24 40
LANTUS 113 110 25 51
AMLODIPINE BESYLATE 112 94 26 6
METOPROLOL SUCCINATE 112 104 26 18
KLOR-CON M20 111 97 28 76
QUETIAPINE FUMARATE 110 100 29 88
METFORMIN HCL 107 87 30 8
DIVALPROEX SODIUM 104 90 31 113
CARBIDOPA-LEVODOPA 102 96 32 104
OXYBUTYNIN CHLORIDE ER 102 91 32 120
FAMOTIDINE 99 97 34 78
EXELON 96 93 35 162
DILTIAZEM ER 96 92 35 139
CLOPIDOGREL 93 89 37 25
ESCITALOPRAM OXALATE 92 91 38 73
KLOR-CON M10 90 77 39 149
ALLOPURINOL 88 59 40 28
FLUOXETINE HCL 87 87 41 46
OLANZAPINE 87 87 41 126
DILTIAZEM 24HR CD 86 82 43 118
CLOTRIMAZOLE 86 69 43 264
TRAZODONE HCL 82 78 45 37
TRAMADOL HCL 77 62 46 14
HYDROCHLOROTHIAZIDE 77 72 46 12
SILVER SULFADIAZINE 76 69 48 276
TAMSULOSIN HCL 75 61 49 32
SANTYL 71 70 50 190
LEVETIRACETAM 71 60 50 110
ATENOLOL 68 64 52 20
MUPIROCIN 67 31 53 188
AZITHROMYCIN 66 60 54 49
ROPINIROLE HCL 65 59 55 91
MELOXICAM 64 49 56 22
CIPROFLOXACIN HCL 63 54 57 56
PLAVIX 63 61 57 39
TORSEMIDE 62 57 59 132
ZOLPIDEM TARTRATE 62 60 59 16
LOSARTAN POTASSIUM 59 45 61 24
PREDNISONE 58 46 62 43
AMIODARONE HCL 58 58 62 156
FLUTICASONE PROPIONATE 55 37 64 29
MEGESTROL ACETATE 54 54 R 65 123
JANTOVEN 54 50 65 170
PAROXETINE HCL 54 41 65 52
IPRATROPIUM-ALBUTEROL 52 50 68 212
BUSPIRONE HCL 50 30 69 121
CARVEDILOL 50 47 69 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.